Advertisement

Picture EBD Group BIO-Europe 2021 Time to Register 650x100

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in France and Monaco or involving organisations from these countries.

Total search results: 1308 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
iOmx Therapeutics–SEVERAL: investment, 202110 financing round Series B €65m co-led by Athos Service GmbH + MIG Capital AG 2021-10-05
Pierre Fabre–Atara Biotherapeutics: tabelecleucel, 202110– collab $45m upfront + $320m milestones + royalties excl sales in EMEA for EBV+ cancers 2021-10-04
Aglaia Therapeutics–Advent France Biotechnology: investment, 202109 seed financing round totalling €4m incl co-founder + lead investor AFB 2021-09-27
Aglaia Therapeutics–Crédit Mutuel-CIC: investment, 202109 seed financing round totalling €4m incl co-investor Crédit Mutuel Innovation 2021-09-27
Aglaia Therapeutics–Pierre Fabre: investment, 202109 seed financing round totalling €4m incl co-investor Pierre Fabre 2021-09-27
Aglaia Therapeutics–SEVERAL: investment, 202109 seed financing round €4m led by Advent FB with Crédit Mutuel Innovation + Pierre Fabre 2021-09-27
Jeito Capital–SEVERAL: investment, 202109 final closing Jeito I with addit €284m at €534m after €200m 1st close + €50m from Sanofi 2021-09-20
Clean Biologics–Andrew Lloyd Associates: public relations, 202109 service existent for Clean Cells by ALA 2021-09-15
Clean Biologics–ArchiMed: investment, 202109 investment existent by ArchiMed 2021-09-15
TreeFrog Therapeutics–BMS: investment, 202109 financing round Series B totalling $75m (€64m) incl co-investor BMS 2021-09-13
TreeFrog Therapeutics–France (govt): investment, 202109 financing round Series B totalling $75m (€64m) incl lead investor Bpifrance Large Venture 2021-09-13
TreeFrog Therapeutics–Leonard Green: investment, 202109 financing round Series B totalling $75m (€64m) incl co-investor Leonard Green + Partners LP 2021-09-13
TreeFrog Therapeutics–SEVERAL: investment, 202109 financing round Series B $75m (€64m) led by Bpifrance Large Venture 2021-09-13
TreeFrog Therapeutics–Siparex: investment, 202109 financing round Series B totalling $75m (€64m) incl exisiting + co-investor XAnge 2021-09-13
Tissium–Cathay Capital: investment, 202108 financing round Series C totalling €50m incl new + co-lead investor Cathay Health 2021-08-31
Tissium–SEVERAL: investment, 202108 financing round Series C €50m co-led by Cathay Health + Sofinnova Partners 2021-08-31
Tissium–Sofinnova: investment, 202108 financing round Series C totalling €50m incl existing + co-lead investor Sofinnova Partners 2021-08-31
Afyren–SEVERAL: investment, 202108– IPO at Euronext Growth Paris registration document filed 2021-08-25
Translate Bio–Sanofi: investment, 202108– cash tender offer $3.2b at $38/share ANNOUNCED 2021-08-03
T-Knife–SEVERAL: investment, 202108 financing round Series B $110m led by new investor Fidelity Management and Research 2021-08-02
Xell AG–Sartorius: investment, 202107 acquisition €50m plus two revenue-based earn-out components in 2022 to 2025 2021-07-29
France (govt)–Jeito Capital: business development, 202107– supply service Rafaèle Tordjman appointed to promote French biotech ecosystem 2021-07-28
Artios Pharma–SEVERAL: investment, 202107 financing round Series C £110m ($153m) co-led by Omega Funds + TCG X 2021-07-27
Abivax–SEVERAL: credit, 202107– convertible bonds €25m at 6% interest/year 2021-07-23
Abivax–SEVERAL: investment, 202107 capital increase €60m with 3% discount with 1.97m shares at €30.55/share 2021-07-23
Voluntis–Aptar: investment, 202106– cash tender offer €78.8m at €8.7/share announced with 64.6% committed by reference shareholders 2021-07-23
Coave Therapeutics–Eurazeo: investment, 202107 financing round Series B extension totalling €21.2m incl existing + co-investor Idinvest 2021-07-21
Coave Therapeutics–eureKARE: investment, 202107 financing round Series B extension totalling €21.2m incl new + co-investor eureKARE 2021-07-21
Coave Therapeutics–Fund+: investment, 202107 financing round Series B extension totalling €21.2m incl existing + co-investor Fund+ 2021-07-21
Coave Therapeutics–GO Capital (FR): investment, 202107 financing round Series B extension totalling €21.2m incl existing + co-investor GO Capital 2021-07-21
Coave Therapeutics–Huntsworth: public relations, 202107 service existent by Medistrava Consulting 2021-07-21
Coave Therapeutics–Kurma Partners: investment, 202107 financing round Series B extension totalling €21.2m incl existing + co-investor Kurma Partners 2021-07-21
Coave Therapeutics–Omnes Capital: investment, 202107 financing round Series B extension totalling €21.2m incl existing + co-investor Omnes Capital 2021-07-21
Coave Therapeutics–Seroba: investment, 202107 financing round Series B extension totalling €21.2m incl lead investor Seroba Life Sciences 2021-07-21
Coave Therapeutics–SEVERAL: investment, 202107 financing round Series B extension €21.2m bringing total Series B to €33.1m 2021-07-21
Coave Therapeutics–Sham: investment, 202107 financing round Series B extension totalling €21.2m incl existing + co-investor Sham Innovation Santé 2021-07-21
Coave Therapeutics–Théa Open Innovation: investment, 202107 financing round Series B extension totalling €21.2m incl new + co-investor Théa OI 2021-07-21
Coave Therapeutics–V-Bio Ventures: investment, 202107 financing round Series B extension totalling €21.2m incl existing + co-investor V-Bio Ventures 2021-07-21
Dopavision–Akampion: public relations, 202107 service existent by Akampion 2021-07-14
Dopavision–Boehringer: investment, 202107 financing round Series A totalling €12m incl existing + co-investor BIVF 2021-07-14
Dopavision–BPCE: investment, 202107 financing round Series A totalling €12m incl new + lead investor Seventure Partners 2021-07-14
Dopavision–Eternity.Health: investment, 202107 financing round Series A totalling €12m incl existing + co-investor Ababax Health 2021-07-14
Dopavision–Novartis: investment, 202107 financing round Series A totalling €12m incl new + co-investor Novartis Pharmaceuticals 2021-07-14
Dopavision–SEVERAL: investment, 202107 financing round Series A €12m led by new investor Seventure Partners 2021-07-14
Sofinnova–SEVERAL: investment, 202107 closing €63m of Sofinnova MD Start III fund 2021-07-13
Micropep Technologies–CEA Industrie: investment, 202107 financing round Series A totalling €8.5m incl new + lead investor Supernova Invest 2021-07-08
Micropep Technologies–FMC: investment, 202107 financing round Series A totalling €8.5m incl new + co-investor FMC Ventures 2021-07-08
Micropep Technologies–Irdi Soridec: investment, 202107 financing round Series A totalling €8.5m incl existing + co-investor Irdi Capital 2021-07-08
Micropep Technologies–SEVERAL: investment, 202107 financing round Series A €8.5m led by Supernova Invest 2021-07-08
Micropep Technologies–Sofinnova: investment, 202107 financing round Series A totalling €8.5m incl existing + co-investor Sofinnova Partners 2021-07-08
CellGenix–Sartorius: investment, 202107 acquisition 51% share for €100m cash by SSB with planned acquisition of remaining shares until 2026 2021-07-02
NFL Biosciences–SEVERAL: investment, 202106–202107 IPO €5m at Euronext Growh Paris with 486.2k shares in France + 829.6k shares globally at €3.8/share 2021-06-30
Xenothera–EU (govt): investment, 202106 financing round totalling €20m incl €10m from new + lead investor EIC Fund 2021-06-29
Xenothera–SEVERAL: investment, 202106 financing round €20m led by new investor EIC Fund with €10m 2021-06-29
Pixium Vision–LifeSci: public relations, 202106 supply service existent LifeSci Advisors is media + IR contact for Pixium Vision 2021-06-25
908 Devices–Sartorius: bioprocess control technology, 202106 collab product integration Rebel media analyzer with SIMCA data exploratory tool 2021-06-22
Corlieve Therapeutics–Uniqure: investment, 202106–202107 acquisition €46.3m upfront cash + €203.7m milestones 2021-06-22
Sirion Biotech–PerkinElmer: investment, 202106– acquisition by PerkinElmer ANNOUNCED 2021-06-22
Mnemo Therapeutics–Alexandria Real Estate: investment, 202106 financing round Series A totalling €75m incl co-investor Alexandria Venture Investments 2021-06-16
Mnemo Therapeutics–Casdin Capital: investment, 202106 financing round Series A totalling €75m incl co-lead investor Casdin Capital 2021-06-16
Mnemo Therapeutics–Emerson Collective: investment, 202106 financing round Series A totalling €75m incl co-investor Emerson Collective 2021-06-16
Mnemo Therapeutics–OTHER: investment, 202106 financing round Series A totalling €75m incl co-lead by undisclosed investor 2021-06-16
Mnemo Therapeutics–Redmile Group: investment, 202106 financing round Series A totalling €75m incl co-investor Redmile Group 2021-06-16
Mnemo Therapeutics–SEVERAL: investment, 202106 financing round Series A €75m led by Casdin Capital + Sofinnova Partners + NN 2021-06-16
Mnemo Therapeutics–Sofinnova: investment, 202106 financing round Series A totalling €75m incl existing + co-lead investor Sofinnova Partners 2021-06-16
Alentis Therapeutics–Bellevue: investment, 202106 financing round Series B totalling CHF60m incl existing + co-investor BB Pureos Bioventures 2021-06-15
Alentis Therapeutics–BioMedPartners: investment, 202106 financing round Series B totalling CHF60m incl existing + co-investor BioMed Partners 2021-06-15
Alentis Therapeutics–France (govt): investment, 202106 financing round Series B totalling CHF60m incl existing + co-investor Bpifrance InnoBio 2 Fund 2021-06-15
Alentis Therapeutics–High-Tech Gründerfonds: investment, 202106 financing round Series B totalling CHF60m incl existing + co-investor HTGF 2021-06-15
Alentis Therapeutics–Jeito Capital: investment, 202106 financing round Series B totalling CHF60m incl new + co-investor Jeito Capital 2021-06-15
Alentis Therapeutics–Morningside: investment, 202106 financing round Series B totalling CHF60m incl new + lead investor Morningside Ventures 2021-06-15
Alentis Therapeutics–Schroders: investment, 202106 financing round Series B totalling CHF60m incl existing + co-investor Schroders Capital 2021-06-15
Alentis Therapeutics–SEVERAL: investment, 202106 financing round Series B CHF60m led by Morningside Venture Investments 2021-06-15
HiFiBio–B Capital Group: investment, 202106 financing round Series D totalling $75m incl new + co-investor B Capital Group 2021-06-14
HiFiBio–Grand Mount: investment, 202106 financing round Series D totalling $75m incl new + co-investor Grand Mount 2021-06-14
HiFiBio–Hengxu: investment, 202106 financing round Series D totalling $75m incl existing + co-investor Hengxu 2021-06-14
HiFiBio–HKSTP Venture Fund: investment, 202106 financing round Series D totalling $75m incl new + co-investor HKSTP Venture Fund 2021-06-14
HiFiBio–IDG Capital: investment, 202106 financing round Series D totalling $75m incl existing + co-investor IDG 2021-06-14
HiFiBio–Legend Star Capital: investment, 202106 financing round Series D totalling $75m incl existing + co-investor Legend Star 2021-06-14
HiFiBio–Maison Capital: investment, 202106 financing round Series D totalling $75m incl new + co-investor Maison Capital 2021-06-14
HiFiBio–Mirae Asset: investment, 202106 financing round Series D totalling $75m incl new + lead investor Mirae Asset Capital 2021-06-14
HiFiBio–Sequoia Capital: investment, 202106 financing round Series D totalling $75m incl existing + co-investor Sequoia Capital China 2021-06-14
HiFiBio–SEVERAL: investment, 202106 financing round Series D $75m led by new investor Mirae Asset Capital 2021-06-14
HiFiBio–Sherpa Healthcare Partners: investment, 202106 financing round Series D totalling $75m incl new + co-investor Sherpa Healthcare Partners 2021-06-14
HiFiBio–Trinity Innovation Fund: investment, 202106 financing round Series D totalling $75m incl new + co-investor TIF 2021-06-14
Advent France Biotechnology–Andrew Lloyd Associates: public relations, 202106 service existent by ALA 2021-06-08
AB Science–Alpha Blue Ocean: investment, before 202106 investment by ABO 2021-06-07
Erytech–Alpha Blue Ocean: investment, before 202106 investment by ABO 2021-06-07
Intrasense–Alpha Blue Ocean: investment, before 202106 investment by ABO 2021-06-07
Pharnext–Alpha Blue Ocean: credit, 202106–202405 convertible bond program up to €81m in 35 tranches with Global Tech Opportunities 13 2021-06-04
Amyl Therapeutics–Mérieux: investment, 202106 financing round Series A totalling €8.6m incl co-investor Mérieux Participations 2021-06-03
Amyl Therapeutics–SEVERAL: investment, 202106 financing round Series A €8.6m led by Noshaq 2021-06-03
L’Oréal–Celonis: management execution software, 202106 supply existent customer L’Oréal 2021-06-02
HalioDx–Veracyte: investment, 202106– acquisition €147m in cash + €113m in stock ANNOUNCED 2021-06-01
Pulmocide–Jeito Capital: investment, 202105 financing round Series C totalling $92m incl new + lead investor Jeito Capital 2021-05-27
Pulmocide–SEVERAL: investment, 202105 financing round Series C $92m led by new investor Jeito Capital 2021-05-27
Swixx Biopharma–Mérieux: investment, 202105– capital increase totalling €45m incl €40m for minority share from new investor MxEP 2021-05-20
Swixx Biopharma–SEVERAL: investment, 202105– capital increase €45m with €40m from new investor MxEP + €5m from existing investor HBM 2021-05-20
Cytoki Pharma–SEVERAL: investment, 202105 financing round Series A $45m led by existing investor Lundbeckfonden Emerge 2021-05-05
MoonLake–Merck (DE): sonelokimab, 202105– license from Merck KGaA 2021-05-03
1 2 3 4 5 6 7 8 9 10 11 12 13 14  next pagenext page



Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [iito] Plain Stupid Simple 650x80px

» top